Education Library

Resources for Health Care Professionals

Filter Results





September 23, 2022

81% Survival at 30 Days in a Multi-Center, Multi-Society Study of Impella®-Supported AMICS Patients in Japan

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan's J-PVAD study at TCT 2022.

August 12, 2022


Babar Basir, MD, highlights key concepts in the NCSI protocol that will be studied in the RECOVER IV randomized controlled trial.

August 11, 2022

Moving the Needle in AMI Cardiogenic Shock Survival

William O’Neill, MD, discusses the need for designing programs to improve outcomes in patients with AMI cardiogenic shock.

June 30, 2022

 The Current State of MCS for AMICS  

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.

June 22, 2022

Postpartum Myocarditis Escalated to Impella 5.5® with SmartAssist®  

This case study describes how escalation of support to Impella 5.5 with SmartAssist enabled heart recovery in a 33-year-old woman with postpartum myocarditis.

June 21, 2022

Optimizing AMICS Patient Care Prior to Leaving the Cath Lab

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

June 16, 2022

Building Collaboration Between Interventionalists and Cardiac Surgeons

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella™.

May 26, 2022

Impella® Placement Pre-PCI for AMI Cardiogenic Shock  

Mario Iannaccone, MD, discusses his meta-analysis data supporting pre-PCI placement of Impella® for AMI cardiogenic shock.


February 2, 2022

Using Administrative/Payer Databases: Limitations and Utility

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

November 4, 2021

TCT 2021: Real World Evidence Leading to RECOVER IV

William O’Neill, MD, discusses the development of best practices for treating AMI cardiogenic shock leading to the RECOVER IV RCT.

October 29, 2021

Data-Driven Point-of-Care Risk Model in Patients with AMICS

Ole Helgestad, PhD, discusses an automated variable selection method for predicting 30-day mortality in patients with AMICS receiving acute PCI. 

October 19, 2021

Eligibility for MCS Based on Cardiogenic Shock RCTs

Benedikt Schrage, MD, discusses his paper examining how enrollment criteria in RCTs apply to the real-world cardiogenic shock patient population.

October 13, 2021

HFSA 2021: Managing AMI Cardiogenic Shock Using the National Cardiogenic Shock Initiative Study Protocol

Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.

September 9, 2021

Fellows Course: ICU & Device Management

Timothy Smith, MD, discusses the importance of the cardiovascular ICU and device management for patients with cardiogenic shock supported with the Impella® heart pump.

May 20, 2021

CRT 2021: PROTECT IV and Beyond with Rajan Patel, MD

Rajan Patel, MD, discusses clinical data supporting Impella® use in Protected PCI and cardiogenic shock at the CRT 2021 virtual annual symposium.